Hydinole Capsule 100 mg (Cefdinir Hydrate)

Adult dose

Adults: Administer 100 mg (potency) of cefdinir orally per dose, 3 times daily. For patients on hemodialysis, administration of 100 mg (potency) once daily is recommended. Increase or decrease the dose as appropriate according to symptoms.

This medication should not be used in certain patients. For example, it should not be given to those who have a history of shock due to this medication or who are allergic to this medication, its components, or cephalosporin antibiotics. Additionally, it should be used cautiously in those with a history of allergy to penicillin, those with a family history of such allergies, patients with allergic constitution, severe renal dysfunction, patients who cannot take oral medications, those with poor general condition, elderly patients, and those with a history of colitis. This medication can rarely cause serious side effects; if symptoms of shock, dyspnea, skin rashes, blood disorders, colitis, interstitial pneumonia, renal dysfunction, or liver dysfunction occur, administration should be stopped immediately and appropriate treatment should be provided. To prevent the emergence of resistant organisms, susceptibility testing should be performed, and it should only be used for the minimum necessary duration. Additionally, it is advisable to examine the patient's history and conduct skin reaction tests prior to prevent hypersensitivity reactions. There may be interactions when taken with iron supplements, warfarin, antacids, probenecid, and adequate time intervals should be maintained between doses. The safety of using this medication during pregnancy has not been established; it should only be used under a physician’s judgment when the benefits outweigh the risks. The safety in children and premature infants has also not been adequately confirmed, so caution is necessary. In elderly patients, side effects may occur more easily due to a decline in physical function, so dosages and intervals should be adjusted while monitoring their condition. In cases of overdose, symptoms such as nausea, vomiting, diarrhea, and seizures may occur, and in severe cases, blood dialysis may be necessary. This medication can affect certain clinical test results, so this should be communicated to the healthcare professionals during testing. Finally, this medication should be kept out of the reach of children and stored away from direct sunlight and moisture.

• Shock
• oral abnormalities
• wheezing
• dizziness
• bowel movements
• tinnitus
• sweating
• respiratory distress
• generalized flushing
• angioedema

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain room temperature between 1 and 30 degrees Celsius.

Appearance

This medication is a light red hard capsule with contents that are a light yellowish-white powder or granules.

Package unit

For domestic use - 30 capsules/bottle, For domestic use - 100 capsules/bottle, For export - 100 capsules/box [10 capsules/PTP*10]